NCT07711028

Brief Summary

urolethiasis (kidney stones) is common globally, with recurrence in 50% of patients.

  • Shock Wave Lithotripsy (SWL) is a minimally invasive treatment for stones \< 2 cm.
  • Hypothesis: Urine pH might influence SWL success and could be manipulated pre-procedure. Aim of the work is to evaluate the role urine pH on the outcomes of shock wave lithotripsy in renal stones. patients and methods The study will be conducted over 146 patients( with single renal stone \< 2 cm) in Urology department of Banha university Hopitals from Dec 2025 till Dec 2026. Exclusions: patients on pH altering drugs, multiple stones,stents. Procedure: SWL Siemens Lithoscope up to 3 sessions per patient. Data collected : Age, BMI, urine pH, specific gravity(SG), stone size, location, Hounsfield unit(HU), skin to stone distance (SSD). Analysis Chi-square\& t-test; significance at p\<0.05. Results Will be tabulated and statistically analyzed

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for not_applicable

Timeline
3mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Jan 2026Oct 2026

Study Start

First participant enrolled

January 20, 2026

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 17, 2026

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Expected
Last Updated

July 20, 2026

Status Verified

July 1, 2026

Enrollment Period

6 months

First QC Date

July 14, 2026

Last Update Submit

July 17, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Stone free rate

    Four weeks

Study Arms (2)

Role of urine PH

NO INTERVENTION

Role of urine PH in shock wave lithotripsy outcomes in renal stone disease

OTHER
Procedure: Shock Wave IithotripsyProcedure: Extracorporeal shock wave lithotripsy

Interventions

ESWL in renal stone disease

Role of urine PH in shock wave lithotripsy outcomes in renal stone disease

The procedures utilized advanced lithotripsy systems, specifically the Siemens Lithoskop and a piezoelectric lithotripter (Piezolith 3000 Plus, Richard Wolf, Germany) equipped with direct-focusing shockwave technology and triple focus size localization capabilities (F1 =2 mm, F2 =4 mm, F3 =8 mm). During the procedure, an integrated ultrasound device was primarily used to locate and continuously monitor the targeted stone in real-time, significantly minimizing radiation exposure. Fluoroscopy was employed only briefly and strictly to confirm the anatomical position and radiolucency of lower calyceal stones. The procedural parameters were standardized across the cohort: the shockwave delivery rate was set at 90 pulses per minute, with a strict safety cap of 3000 shockwaves per session. The mechanical fragmentation strategy utilized a progressive focusing technique. Treatment commenced with the smallest focal size (F1) to safely initiate stone breakdown.

Role of urine PH in shock wave lithotripsy outcomes in renal stone disease

Eligibility Criteria

Age18 Years - 60 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Single renal calculus.
  • Stones less than 2 cm in its maximum diameter.

You may not qualify if:

  • Patients receiving any pH-altering medications.
  • Patients have multiple renal stones.
  • Patients have indwelling ureteral stents.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benha University Hospitals

Banhā, Benha, 74111, Egypt

Location

MeSH Terms

Interventions

Lithotripsy

Intervention Hierarchy (Ancestors)

TherapeuticsUltrasonic Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Model Details: Shock Wave Lithotripsy Protocol All SWL interventions were performed as outpatient procedures. Patients underwent a maximum of three treatment sessions. The procedures utilized advanced lithotripsy systems, specifically the Siemens Lithoskop and a piezoelectric lithotripter (Piezolith 3000 Plus, Richard Wolf, Germany) equipped with direct-focusing shockwave technology and triple focus size localization capabilities (F1 =2 mm, F2 =4 mm, F3 =8 mm). During the procedure, an integrated ultrasound device was primarily used to locate and continuously monitor the targeted stone in real-time, significantly minimizing radiation exposure. Fluoroscopy was employed only briefly and strictly to confirm the anatomical position and radiolucency of lower calyceal stones. The procedural parameters were standardized across the cohort: the shockwave delivery rate was set at 90 pulses per minute, with a strict safety cap of 3000 shockwaves per session.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor Dr

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 17, 2026

Study Start

January 20, 2026

Primary Completion

July 20, 2026

Study Completion (Estimated)

October 31, 2026

Last Updated

July 20, 2026

Record last verified: 2026-07

Locations